Torrent Pharma posted a 1 per cent dip in net profit at ₹204 crore for the quarter ended September 2017 as against ₹207 crore reported in the corresponding quarter a year ago.
Company's revenues for the quarter stood at ₹1,429 crore.
EBIDTA was at ₹405 crore as against ₹372 crore during the same period last year, showing 9 per cent growth.
In the first half period of April-September, the company reported a 21 per cent dip in net profit at ₹392 crore, against ₹499 crore reported in the same period last year.
Revenues for the period fell 6 per cent to ₹2,803 crore, against ₹2,980 crore in the corresponding period a year ago.